Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation
- 31 May 2005
- journal article
- Published by Elsevier in Heart Rhythm
- Vol. 2 (5) , 525-529
- https://doi.org/10.1016/j.hrthm.2005.01.016
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 1Published by Elsevier ,2004
- Endothelial microparticles as markers of endothelial dysfunctionFrontiers in Bioscience-Landmark, 2004
- Cellular microparticles: what are they bad or good for?Journal of Thrombosis and Haemostasis, 2003
- Atrial Fibrillation and StrokeStroke, 2001
- Vascular sodium pump endothelial modulation and alterations in some pathological processes and agingPharmacology & Therapeutics, 1999
- In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulantJournal of Clinical Investigation, 1999
- Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation.Stroke, 1989
- Effects of Ouabain on86Rb‐Uptake,3H‐5‐HT‐Uptake and Aggregation by 5‐HT and ADP in Human PlateletsBasic & Clinical Pharmacology & Toxicology, 1988
- Binding of [3H]ouabain to endothelial cells derived from various vascular bedsBasic Research in Cardiology, 1987
- Ouabain affects platelet reactivity as measured in vitroThrombosis Research, 1987